Shames Richard S. 4
4 · Protagonist Therapeutics, Inc · Filed Aug 30, 2017
Insider Transaction Report
Form 4
Shame Richard S
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2017-08-29$4.21/sh+1,512$6,366→ 3,377 total - Sale
Common Stock
2017-08-29$17.00/sh−1,512$25,704→ 1,865 total - Exercise/Conversion
Stock Option (right to buy)
2017-08-29−1,512→ 38,819 totalExercise: $4.21Exp: 2026-04-29→ Common Stock (1,512 underlying)
Footnotes (3)
- [F1]Includes 1,865 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2017.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017.
- [F3]The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.